All lobbying filings

SACHEM STRATEGIES

Lobbying for STRAND THERAPEUTICS · mRNA therapeutics company

Filing Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

HOUSE OF REPRESENTATIVES
Natl Security Council (NSC)
SENATE
State, Dept of (DOS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to biomanufacturing policy (no specific legislation).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.